Drug and Therapeutics Bulletin 1999;37:87-88
Copyright © 1999 by the BMJ Publishing Group Ltd.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation

Topical NSAIDs for joint disease

Relevant BNF section: 10.3.2

Over 20 proprietary topical preparations of non-steroidal anti-inflammatory drugs (NSAIDs) are now available, both 'over the counter' and on prescription. They are licensed for the treatment of pain due to 'non-serious' arthritic conditions and/or soft tissue injuries. In the early 1990s, we could find little evidence to support the use of these products rather than simple analgesics or oral NSAIDs for acute soft tissue injuries, and even less for chronic inflammatory and degenerative joint diseases.1,2 Here, we reconsider the place of topical NSAIDs, concentrating on their use in chronic arthritic conditions.






About DTB - Privacy policy - Terms and conditions relating to subscriptions purchased online - Web site terms and conditions - Feedback

© 1999 BMJ Publishing Group Ltd.